Gene Therapy, Bioprocessing, China Plan
Kilder
- BioPharma Dive: Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug
- Finance: Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug - Yahoo Finance
- BioPharma Dive: Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug
- Finance: Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug - Yahoo Finance
- Endpoints: China sets ambitious goals for global biopharma expansion in new five-year plan
- GEN: Model-Free, Pure Component Analysis Could Help Biopharma Cut Costs
- GEN: Nu-Tek Brings Topic of Raw-Material Risk to BPI - Genetic Engineering and Biotechnology News
- GEN: Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop Virus-Filtration System - Genetic Engineering and Biotechnology News
- Endpoints: Legend names new CEO as Carvykti competition grows; Vertex makes a flurry of moves
- Labiotech: The best biotech conversations you missed this summer
- Finance: Nanobiotics' Lévy: The Liver Blocks Nearly 100% of Injected Therapies — One in a Million Reaches the Target - finance.biggo.com
- GEN: The Saga of Sickle Cell Disease
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.